| Micro-channel |
 |
|
|
|
|
|
| |
| It is still difficult to find the price of the price of the drug which has doubled in price |
| |
| Author：中國銘鉉 企劃部 Release Time：2017-8-8 10:59:46 Number Browse：601 |
| |
Medical network - on August 8, according to the voice of China "news network" report, erythromycin eye ointment and compound liquorice tablets is a lot of families, a necessary medicine, mosquito bites, little ailments such as colds cough disaster can be used, the price of a few cents left many good memories. These families common medicine recently began to rise in price, however, in some places, appear even doubling the rise in the price of cheap drugs, some drug prices 20 times within a year, even if such a medicine still is hard to find. Where's the cheap medicine that people are familiar with? Who is driving the rise in drug prices?
Jinan citizens ms Yang eyes recently were mentioned, the thought of community service center to buy a few of erythromycin eye ointment spare more, only to be told that has been out of stock, but not sure what time can come again. Ran three or four pharmacies, and ms Yang bought erythromycin eye ointment, finally let her unexpected is, just a half years, originally a few cents a ointment has been up to four six, "although not too expensive, can afford it, but such a short time from a few hair up to that price, mentally can't accept it."
The reporter then made a visit to several pharmacies in jinan, and found that the price of erythromycin eye ointment has gone up, and the price of drugs like glutamate, lipitor, and licorice tablets has gone up several times. In the past six cents a bottle of glutamine has now risen to 8.5 yuan a bottle; A box of seven yuan for lipitor, a coronary heart disease, now costs more than 60 yuan per box. The price of the high-tri-picolinine injection, which is used to treat acute undribbub leukemia, has risen from $5 a year ago to $110 now, and the price has soared more than 20 times.
In fact, the shortage of cheap medicines in jinan and a big increase in prices are not an isolated case in the country. In recent years, in the country, the news that cheap medicine is frequently in rush has been exposed. At the end of 2015, a 13-year-old patient in anhui province, in need of a cheap "lifesaving drug" pingyangmycin, found only 4 boxes of stocks in anhui province. In 2016, there was a drug shortage in the Ming tablets of brompyrime, and many of the country's most myasthenia patients were looking for the life-saving drug, and the price of the cheap drug was also priced from 33 yuan to 280 yuan.
Shandong zhi-qiang ma, head of a pharmaceutical company, said cheap medicine prices do not rule out some drug firms through monopoly raise drug prices, "such as a period of time before more hot speculation protamine, may be only two production, is one of the manufacturers in Beijing in the north, the south is the enterprise production in Shanghai, they unite to corner the market, put pressure on the government and society to raise prices, this kind of phenomenon also is some."
Besides price monopoly, the price increase of cheap drugs is more of a market action. Many companies have had to stop production when costs such as raw materials, artificial, logistics and so on are rising, even as they are closing in on prices. The closure of companies is bound to increase the supply of cheap drugs, boosting the price of cheap drugs. Some research and development of pharmaceutical industry in shandong, liu said, head of cheap drugs is considered to be "has the curative effect and no money", any a pharmaceutical production enterprise can bear at production, they find it hard to only rely on the conscience and responsibility, "don't increase the price just waiting to die, it's really a lot of cheap medicines disappeared, some pharmaceutical factory is compelling.clients, original price can not maintain, such as low medicine also can not upper after bidding, even after the upper does not necessarily have to sell."
When it comes to producing cheap drugs, some companies play a "new bottle of old wine" trick. The same medicine, changing the name, changing the packaging, changing the document, can double or even dozens of times. As a result, some cheap drugs take off the "cheap" overcoat to rebrand new packaging, and each change means a surge in prices. Taking anti-inflammatory drugs as an example, the transformation from tetracycline to amoxicillin to cephalospore, followed by the price from a few cents to four or five dollars to more than twenty dollars.
Represented by erythromycin eye ointment and compound liquorice tablets of cheap drugs, basic drugs, also known as means to meet the demand of basic medical and health care, appropriate, to ensure supply of dosage form, at the grass-roots level can be equipped with, national can equitable access to medicines. However, yu mingde, President of the China association of pharmaceutical enterprises and Chinese pharmaceutical entrepreneur association, said at the 2016 national two sessions that cheap drugs are disappearing at a rate of dozens of species per year. Even if the curative effect is good, but the price of medicine is low, the enterprise does not produce, common people is not medicine to buy, cheap medicine is entering a dead cycle. How to crack the shortage of cheap drugs?
To this, the national health care expert advisory committee of the state council liu gg believes that the supply of cheap drugs to the government's "visible hand" to the palm, "through market means is not solve, there is only one way, by the hand of the government's public finances is wholly owned the palm pharmaceutical factory, held a number of government to keep it at a loss, the government out of public finance, then can solve this problem."
Industry insiders say the current shortage of cheap medicines is hard to change. In the future of medicine, only the government, drug companies and hospitals will continue to play the game and eventually find a market equilibrium that will allow cheap drugs to flow into patients' hands.
|
| |
Previous article：Blood products sprint 40 billion market, closely watch key enterprise performance
Next article：China's best-selling TOP20 brand after the overhaul of health care reform?
|
| |
|
|
